409254
Position
Director, Multiple Myeloma Program, Medical Oncology
Bio
My research focuses on understanding the biology of multiple myeloma and development of novel therapeutics for the treatment of myeloma. On the basic front I have been involved with undersatnding the role of B cell activating factor (BAFF) and cyclin d dysregulation in myeloma. I am also involved with understanding the biology of bone disease in myeloma. On the translational front, we have several interesting antibodies and small molecules including BAFF antibody and cyclin D 1 inhibitors which have been validated preclinically and will be translated to phase I/II clinical studies for relapsed refractory myeloma.
Interests
None yet.